The malignant signature gene of cancer-associated fibroblasts serves as a potential prognostic biomarker for colon adenocarcinoma patients
We developed a risk model for genes related to the malignancy of CAFs and identified <i>FNDC5</i> as a potential therapeutic target for COAD.
Authors
- Jǐnjīng Xǔ (ORCID: https://orcid.org/0000-0001-7698-5991)
- Ziye Zhuang (ORCID: https://orcid.org/0009-0001-0128-1778)
- Hao Zhang (ORCID: https://orcid.org/0009-0004-2465-2799)
- Hong Li (ORCID: https://orcid.org/0000-0001-6268-8662)
- Ruipeng Wang (ORCID: https://orcid.org/0000-0001-8661-4078)
- Youyuan Tang
Institutions
- Soochow University (CN)
- First Affiliated Hospital of Soochow University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-17
- DOI
- https://doi.org/10.3389/fimmu.2025.1589678
- Citations
- 1
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.47